JAMA Network
What The Study Did: Researchers describe the assessment and immunization of highly allergic individuals with the Pfizer-BioNTech COVID-19 vaccine, as well as the rate of adverse reactions to the vaccine in this population.
Authors: Nancy Agmon-Levin, M.D., of the Sheba Medical Center in Tel Hashomer, Israel, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.22255)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
